Novo Nordisk has filed nine lawsuits in the US after finding counterfeit copies of Wegovy
Novo Nordisk has filed nine new lawsuits in the US against weight-loss clinics, medical spas, pharmacies and other businesses that Novo Nordisk alleges falsely claimed to sell products containing semaglutide, the active ingredient in its weight-loss drug Wegovy.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.